Privia Health Group (NASDAQ:PRVA) Price Target Raised to $31.00 at Citizens Jmp

Privia Health Group (NASDAQ:PRVA) had its target price upped by Citizens Jmp from $30.00 to $31.00 in a research report released on Friday morning,Benzinga reports. Citizens Jmp currently has a market outperform rating on the stock.

Several other brokerages also recently issued reports on PRVA. Weiss Ratings reiterated a “sell (d+)” rating on shares of Privia Health Group in a report on Wednesday, October 8th. Citigroup reaffirmed an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. JMP Securities upped their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Friday, August 29th. Piper Sandler dropped their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research report on Monday, August 11th. Finally, Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Twelve research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.25.

Privia Health Group Trading Down 2.3%

Shares of PRVA traded down $0.55 on Friday, reaching $23.43. The company’s stock had a trading volume of 1,382,680 shares, compared to its average volume of 791,019. Privia Health Group has a twelve month low of $18.77 and a twelve month high of $26.51. The stock has a market capitalization of $2.88 billion, a PE ratio of 180.24, a PEG ratio of 3.27 and a beta of 0.83. The firm has a fifty day moving average of $24.15 and a 200-day moving average of $22.77.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. As a group, equities analysts anticipate that Privia Health Group will post 0.14 EPS for the current fiscal year.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors have recently added to or reduced their stakes in PRVA. CWM LLC increased its holdings in Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after acquiring an additional 2,567 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its position in shares of Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after acquiring an additional 3,173 shares during the period. Vestcor Inc bought a new position in shares of Privia Health Group during the 1st quarter valued at approximately $76,000. Finally, Canada Pension Plan Investment Board increased its stake in shares of Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.